Navigation Links
Human Genome Turns 10
Date:3/31/2010

Scientists reflect on fruits of mapping the genetic blueprint for humans

WEDNESDAY, March 31 (HealthDay News) -- A decade after the sequencing of the human genome, scientists muse on how far they've come and how far there is still to go.

Without doubt, the publication of the genome draft in 2001 permanently altered the scientific and medical landscape, although changes to individual lives are slower to come, according to scientists writing in the April 1 issue of Nature.

"It's still a fairly early stage in the transformation," said Dr. Francis Collins, director of the U.S. National Institutes of Health. "Most people's medical care has probably not been directly affected so far by things that have come along since then. Most of the revolution lies ahead in the next 10 to 20 years."

Collins was director of the National Human Genome Research Institute from 1993 until 2008.

For his piece in Nature, Collins dug up old PowerPoint slides to find predictions he had made in 2000 for 2010. Most have come true.

For instance, he was correct in anticipating that predictive genetic tests would be available for various medical conditions, along with interventions to reduce the associated risk.

Tests for the BRCA1 and BRCA2 genes, which elevate a woman's risk for breast and ovarian cancer, are now commonplace, as are assays to identify people who are at higher risk for colon cancer because they have specific gene mutations.

And once found, there are ways to minimize the genetic dangers. In the case of the BRCA genes, this may mean removing the ovaries or breasts in return for a risk reduction of almost 100 percent. For those genetically at higher risk for colon cancer, annual colonoscopies starting at age 30 instead of 50 saves lives.

Mapping the genetics of tumors has resulted in the development of drugs that more accurately and effectively target weaknesses in cancers. Place the breast cancer drug Herceptin, which targets the HER2/neu receptor, in this category.

Using genetic testing, doctors can now also predict the response of particular tumors to particular drugs, or rule out toxic therapies that aren't needed.

"One breast cancer test that is a direct consequence of our understanding of our genome allows women with negative lymph nodes at the time of surgery to find out whether they need to go through chemo or not, which can prevent a great deal of unpleasantness and is saving our health-care system about $100 million this year," Collins noted.

What hasn't happened?

"We aren't able to predict who's at risk for more common diseases, like coronary artery disease or hypertension or stroke or asthma," said Dr. Robert Marion, chief of genetics and development medicine and director of the Center for Congenital Disorders at Children's Hospital at Montefiore Medical Center in New York City and author of Genetic Rounds: A Doctor's Encounters in the Field that Revolutionized Medicine.

And while "the $1,000 genome is virtually a reality," said Dr. James P. Evans, editor-in-chief of Genetics in Medicine and a spokesman for the American College of Medical Genetics, "interpreting that information will be a monumental task; one that makes the Human Genome Project look like small potatoes."

"Whole genome sequencing will be the first medical test in history which is guaranteed to be abnormal in every single person who undergoes it," Evans added. "We are all mutants. The challenge will be how to interpret and use that information for better health, and that path is a much more complicated one than simply deriving the basic genomic sequence of a representative human."

What does Collins predict will happen now?

The cost of sequencing the human genome could drop even lower than $1,000, he said. "There will be increasing reasons for each of us to have our complete genomes determined and placed in medical files," Collins noted.

"Five years after that, there will be compelling enough evidence that this is good medicine for both prevention and treatment that third parties will cover the cost," Collins said. "Health-care providers will have immediate access to [this information] about you, about what decisions to recommend. It's not one-size-fits-all, but really just about you."

"When I was in training, genetics was a small insignificant subspecialty of pediatrics," Marion noted. "And now pediatrics is a small insignificant subspecialty of genetics."

More information

Visit the U.S. Department of Energy Office of Science for more on the Human Genome Project.



SOURCES: Francis Collins, M.D., Ph.D., director, U.S. National Institutes of Health, Bethesda, Md.; Robert Marion, M.D., chief, genetics and development medicine, and director, Center for Congenital Disorders, Children's Hospital at Montefiore Medical Center, New York City; James P. Evans, M.D., Ph.D., editor-in-chief, Genetics in Medicine and spokesman, American College of Medical Genetics; April 1, 2010, Nature


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Tiny Fish Might Help Humans Fix Damaged Hearts
2. Leading Healthcare Human Resource Consulting Firm, Integrated Healthcare Strategies, Launches New Website
3. Humans Tree-Dwelling Ancestors May Have Also Walked Upright
4. New Exhibition Hall Devoted to Human Origins Opens at National Museum of Natural History
5. Justice Department Files for Immediate Relief Regarding Conditions at Conway Human Development Center, in Conway, Arkansas
6. Infectious Virus Hides In Human Chromosomes During Latency And Can Be Passed From Parents To Their Children
7. Alzheimers Association Honors Social Security Commissioner Michael Astrue With Humanitarian Award
8. Gene Sequencing Yields Picture of Human Gut
9. Master Zhi Gang Sha Dedicates Soul Healing Blessings for Humanity Service to Chile's Earthquake Victims
10. March of Dimes President Dr. Jennifer L. Howse Wins Prestigious Humanitarian Award
11. Ghrelin mitigates liver fibrosis in animal models; regulates human fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... First Choice Emergency Room , the ... Tat Nguyen, as the Medical Director of its new DeSoto facility. , “We ... new DeSoto location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:5/24/2016)... ... May 24, 2016 , ... Sterling Global Products is launching a ... patented refillable hanging wipe dispenser. The campaign kick-off video is located via this link ... 25, 2016. The goal is to raise $1,000 per day for a total of ...
(Date:5/24/2016)... Michigan (PRWEB) , ... May 24, 2016 , ... ... Nurse Midwife, Roberta Jordan. , Roberta Jordan is a Certified Nurse Midwife ... Grand Valley State University and then went on to complete her masters degree ...
(Date:5/24/2016)... ... 2016 , ... Educational opportunities, and therefore life chances, have ... providing richer opportunities. Recognizing the key role of housing in this system, equity-minded ... choice policies; (c) school desegregation policies; (d) wealth-focused policies; and (e) housing-focused policies. ...
(Date:5/24/2016)... ... May 24, 2016 , ... Regenerative Medicine is being transformed ... stem cell therapy technology, protocols and patient results as have been achieved with ... a more accessible standard of care for patients worldwide. , As the Medical Advisory ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... Nev. , May 24, 2016  Diana Russell ... "eats" her organs from the inside out.  This disease ... completely dependent on her children and grandchildren to leave ... her wheelchair, Diana,s family cannot haul the wheelchair.  So ... in the car, and Diana is left to wait ...
(Date:5/24/2016)... 24, 2016 Celsion Corporation (NASDAQ: ... today provided an update on its ongoing OVATION ... combining GEN-1, the Company,s DNA-based immunotherapy, with the ... patients with advanced ovarian cancer who will undergo ... is an IL-12 DNA plasmid vector formulated as ...
(Date:5/24/2016)... KONG , May 24, 2016 ... stent de doble terapia del mundo, introduce catéteres ... arteriovenosa. OrbusNeich, una compañía global especializada ... las vidas, ha expandido su cartera incluyendo productos ... balón JADE™ y Scoreflex™ PTA son los dispositivos ...
Breaking Medicine Technology: